|
Vaccine Detail
Influenza virus DNA vaccine pDNA encoding M2 and NP |
Vaccine Information |
- Vaccine Name: Influenza virus DNA vaccine pDNA encoding M2 and NP
- Target Pathogen: Influenza virus
- Target Disease: Influenza (flu)
- Vaccine Ontology ID: VO_0004355
- Type: DNA vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Mouse
- M2 from Influenza A virus (A/Puerto Rico/8/34(H1N1))
gene engineering:
- Type: DNA vaccine construction
- Description: This DNA vaccine used the plasmid vector VR10551 to express highly‑conserved influenza gene M2 (Jimenez et al., 2007).
- Detailed Gene Information: Click Here.
- NP from Influenza A virus (A/Puerto Rico/8/34(H1N1))
gene engineering:
- Type: DNA vaccine construction
- Description: This DNA vaccine used the plasmid vector VR10551 to express highly‑conserved influenza gene NP (Jimenez et al., 2007).
- Detailed Gene Information: Click Here.
- DNA vaccine plasmid: VR10551 DNA vaccine plasmid
- Immunization Route: intranasal immunization
|
Host Response |
Mouse Response
- Vaccine Immune Response Type: VO_0000286
- Immune Response: For instance, NP + M2 may induce both CD4 and CD8 T-cell responses against both antigens and a humoral immune response against the extracellular domain of M2 which collectively contribute to antiviral immunity (Jimenez et al., 2007)
- Efficacy: 100% protection from challenge with A/HK/8/68 (H3N2) was provided in mice by Vaxfectin-formulated NP+M2 (Jimenez et al., 2007).
|
References |
Jimenez et al., 2007: Jimenez GS, Planchon R, Wei Q, Rusalov D, Geall A, Enas J, Lalor P, Leamy V, Vahle R, Luke CJ, Rolland A, Kaslow DC, Smith LR. Vaxfectin-formulated influenza DNA vaccines encoding NP and M2 viral proteins protect mice against lethal viral challenge. Human vaccines. 2007; 3(5); 157-164. [PubMed: 17637571].
|
|